Schedule 13G ownership disclosure
Strongbridge Biopharma plc
Security class unavailable · CUSIP: G85347105
Event date: 2016-12-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.5200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-005782
- Form type
- SC 13G
- Filer
- Strongbridge Biopharma plc
- CIK
- CIK 1634432
- Filed
- Jan 09, 2017
- Reporting period
- Dec 28, 2016
- Description
- Schedule 13G beneficial ownership